4GARCIA-T SAO G,SANYAL A J,GRACE N D,et al.A-ASLD guidelines:prevention and management of gastroesophugeal varices and variceal nemorrhage in cirrhosis[J].Hepatology,2007,46:922-936.
5KUIPER J J,VAN BUUREN H R,DE MAN R A.Ascites in cirrhosis:a review of management and complications[J].Neth J Med,2007,65:283-288.
6SALERNO F,GREBES A,GINES P,et al.Diagnosis,prevention and treatment of hepatorenal syndrome in cirrhosis[J].Gut,2007,56:1 310-1 318.
1Mandal AK, Ghosh D, Sarkar S,et al. Nanocapsulated quercetindownregulates rat hepatic MMP-13 and controls diethylnitrosamine-induced carcinoma[J]. Nanomedicine, 2014,(1): 1-15.
2He F,Chen EQ’Liu L,et al. Inhibition of hepatitis B virus rep-lication by hepatocyte nuclear factor 4-alpha specific short hair-pin RNA[J]. Liver Int,2012,32(5) :742-751.
